PE20081702A1 - Derivados de benzoquinazolina que promueven la liberacion de la hormona paratiroides - Google Patents
Derivados de benzoquinazolina que promueven la liberacion de la hormona paratiroidesInfo
- Publication number
- PE20081702A1 PE20081702A1 PE2008000160A PE2008000160A PE20081702A1 PE 20081702 A1 PE20081702 A1 PE 20081702A1 PE 2008000160 A PE2008000160 A PE 2008000160A PE 2008000160 A PE2008000160 A PE 2008000160A PE 20081702 A1 PE20081702 A1 PE 20081702A1
- Authority
- PE
- Peru
- Prior art keywords
- release
- propargyloxy
- quinazolin
- methanone
- benzo
- Prior art date
Links
- 102000003982 Parathyroid hormone Human genes 0.000 title abstract 3
- 108090000445 Parathyroid hormone Proteins 0.000 title abstract 3
- 239000000199 parathyroid hormone Substances 0.000 title abstract 3
- 229960001319 parathyroid hormone Drugs 0.000 title abstract 3
- PQIUGRLKNKSKTC-UHFFFAOYSA-N benzo[h]quinazoline Chemical class N1=CN=C2C3=CC=CC=C3C=CC2=C1 PQIUGRLKNKSKTC-UHFFFAOYSA-N 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
- -1 4-ISOPROPYL-PHENYL Chemical class 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
REFERIDA A UN COMPUESTO DERIVADO DE 2-BENZOQUINAZOLINA DE FORMULA (I), DONDE R ES UN GRUPO DE DOS ANILLOS FUSIONADOS A-B, DONDE A ES HETEROARILO O ARILO Y B ES UN ANILLO SATURADO O INSATURADO DE 4, 5, 6 O 7 MIEMBROS QUE CONTIENE UNO O MAS HETEROATOMOS TALES COMO O, N Y/O S; R ES OXO, CIANO, HALOGENO, ALQUILO C1-C6, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: (2,3-DIHIDRO-BENZO-[1,4]-DIOXIN-6-IL)-[4-(4-ISOPROPIL-FENIL)-6-PROPARGILOXI-QUINAZOLIN-2-IL]-METANONA, BENZO-[1,3]-DIOXOL-5-IL-[4-(4-ISOPROPIL-FENIL)-6-PROPARGILOXI-QUINAZOLIN-2-IL]-METANONA, (2,3-DIHIDRO-BENZO-FURAN-5-IL)-[4-(4-ISOPROPIL-FENIL)-6-PROPARGILOXI-QUINAZOLIN-2-IL]-METANONA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UN PROCESO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS PROMUEVEN LA LIBERACION DE LA HORMONA PARATIROIDE (PTH) Y SON UTILES EN EL TRATAMIENTO DE CONDICIONES OSEAS ASOCIADAS CON MAYOR CONSUMO O RESORCION DE CALCIO, ENTRE OTRAS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07100937A EP1956019A1 (en) | 2007-01-22 | 2007-01-22 | Benzoquinazoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20081702A1 true PE20081702A1 (es) | 2008-12-31 |
Family
ID=39523605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008000160A PE20081702A1 (es) | 2007-01-22 | 2008-01-18 | Derivados de benzoquinazolina que promueven la liberacion de la hormona paratiroides |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20100099670A1 (es) |
| EP (2) | EP1956019A1 (es) |
| JP (1) | JP2010516647A (es) |
| KR (1) | KR20090101275A (es) |
| CN (1) | CN101578280A (es) |
| AR (1) | AR064964A1 (es) |
| AU (1) | AU2008209103A1 (es) |
| BR (1) | BRPI0806888A2 (es) |
| CA (1) | CA2674921A1 (es) |
| CL (1) | CL2008000169A1 (es) |
| EA (1) | EA200900941A1 (es) |
| MX (1) | MX2009006308A (es) |
| PE (1) | PE20081702A1 (es) |
| TW (1) | TW200836742A (es) |
| WO (1) | WO2008089933A2 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009148052A1 (ja) | 2008-06-05 | 2009-12-10 | 旭化成ファーマ株式会社 | スルホンアミド化合物及びその用途 |
| JP5654246B2 (ja) * | 2010-03-03 | 2015-01-14 | 一般社団法人ファルマバレープロジェクト支援機構 | キナゾリン化合物を有効成分とする医薬組成物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0230015D0 (en) * | 2002-12-23 | 2003-01-29 | Novartis Ag | Organic compounds |
| GB0516723D0 (en) * | 2005-08-15 | 2005-09-21 | Novartis Ag | Organic compounds |
-
2007
- 2007-01-22 EP EP07100937A patent/EP1956019A1/en not_active Withdrawn
-
2008
- 2008-01-18 PE PE2008000160A patent/PE20081702A1/es not_active Application Discontinuation
- 2008-01-18 AR ARP080100237A patent/AR064964A1/es not_active Application Discontinuation
- 2008-01-21 MX MX2009006308A patent/MX2009006308A/es not_active Application Discontinuation
- 2008-01-21 JP JP2009545877A patent/JP2010516647A/ja active Pending
- 2008-01-21 KR KR1020097015314A patent/KR20090101275A/ko not_active Withdrawn
- 2008-01-21 TW TW097102238A patent/TW200836742A/zh unknown
- 2008-01-21 AU AU2008209103A patent/AU2008209103A1/en not_active Abandoned
- 2008-01-21 BR BRPI0806888-7A patent/BRPI0806888A2/pt not_active IP Right Cessation
- 2008-01-21 CA CA002674921A patent/CA2674921A1/en not_active Abandoned
- 2008-01-21 EP EP08707148A patent/EP2106400A2/en not_active Withdrawn
- 2008-01-21 US US12/523,133 patent/US20100099670A1/en not_active Abandoned
- 2008-01-21 CL CL200800169A patent/CL2008000169A1/es unknown
- 2008-01-21 WO PCT/EP2008/000415 patent/WO2008089933A2/en not_active Ceased
- 2008-01-21 EA EA200900941A patent/EA200900941A1/ru unknown
- 2008-01-21 CN CNA2008800018506A patent/CN101578280A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EA200900941A1 (ru) | 2010-02-26 |
| WO2008089933A3 (en) | 2008-09-12 |
| AR064964A1 (es) | 2009-05-06 |
| EP1956019A1 (en) | 2008-08-13 |
| JP2010516647A (ja) | 2010-05-20 |
| BRPI0806888A2 (pt) | 2014-04-29 |
| AU2008209103A1 (en) | 2008-07-31 |
| MX2009006308A (es) | 2009-08-13 |
| WO2008089933A2 (en) | 2008-07-31 |
| CN101578280A (zh) | 2009-11-11 |
| CL2008000169A1 (es) | 2008-08-08 |
| CA2674921A1 (en) | 2008-07-31 |
| KR20090101275A (ko) | 2009-09-24 |
| EP2106400A2 (en) | 2009-10-07 |
| US20100099670A1 (en) | 2010-04-22 |
| TW200836742A (en) | 2008-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20091724A1 (es) | Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7 | |
| PE20221628A1 (es) | Compuestos inhibidores de rip1 y metodos para hacer y utilizar los mismos | |
| PE20121479A1 (es) | Inhibidores del virus de la hepatitis c | |
| PE20091466A1 (es) | Derivados de 4,5-dihidro-oxazol-2-il-amina | |
| PE20140703A1 (es) | Derivados de heteroarilo como moduladores de nachr alfa 7 | |
| PE20131143A1 (es) | Nuevas aminopirazoloquinazolinas | |
| PE20120659A1 (es) | Inhibidores de la replicacion del virus de la inmunodeficiencia humana | |
| PE20110028A1 (es) | Derivados de isoxazol y su uso como potenciadores de los receptores metabotropicos de glutamato | |
| PE20081831A1 (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona | |
| PE20061106A1 (es) | Derivados de 2-(4-oxo-4h-quinazolin-3-il)acetamida | |
| PE20141203A1 (es) | Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas | |
| PE20141110A1 (es) | Derivados heterociclicos novedosos para el tratamiento de trastornos neurologicos | |
| PE20091000A1 (es) | Inhibidores de la replicacion del virus de la inmunodeficiencia humana | |
| PE20091734A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
| PE20090890A1 (es) | Compuestos derivados de 1-(2,3-dihidrobenzo[1,4]dioxin-2-ilmetil)azaciclos como antagonistas del suptipo adrenoreceptor alfa2c | |
| PE20190968A1 (es) | Compuestos de heterociclo tetraciclicos utiles como inhibidores de la integrasa del vih | |
| PE20090899A1 (es) | Derivados de aminobenceno como moduladores del receptor de androgeno | |
| PE20061335A1 (es) | Compuestos derivados de benzodioxano y benzodioxolano como moduladores del receptor 5-ht2c | |
| PE20120898A1 (es) | Inhibidores de dihidroorotato deshidrogenasa como compuestos virostaticos | |
| PE20121522A1 (es) | Derivados de acido 5-alquinil-3-amida-2-tiofeno-carboxilico como inhibidores del virus flaviviridae | |
| CO6300954A2 (es) | Derivados de tienopiridinonas como activadores de proteina quinasa activados por ampk | |
| PE20121500A1 (es) | 2-amino-5,5-difluor-5,6-dihidro-4h-oxazinas como inhibidores de bace 1 y/o bace 2 | |
| PE20140608A1 (es) | Analogos de nucleotidos sustituidos | |
| BRPI0608221A2 (pt) | métodos para preparação de um composto, e para preparar seletivamente um composto de nitrila, e, composto | |
| PE20130401A1 (es) | Heteroaril-ciclohexil-tetraazabenzo[e]azulenos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |